Pricing

TRIUS THERAPEUTICS INC

0 followers ·
SAN DIEGO CA
Trius Therapeutics is based out of San Diego. Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics for serious, life-threatening infections in the United States. Its products under development include Torezolid Phosphate, which has completed phase 2 clinical trials for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus. The company is also developing antibiotics for gram-negative infections using its proprietary discovery platform under a contract funded by the National Institutes of Health. It has a cooperative research and development agreement with Lawrence Livermore National Security, LLC for the research and development of gram-negative biodefense pathogens; and a license agreement with Dong-A Pharmaceutical Co., Ltd. to develop and sell Torezolid Phosphate outside of Korea. Whalewisdom has at least 52 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-06-07. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

TRIUS THERAPEUTICS INC
6310 NANCY RIDGE DR SUITE 105
SAN DIEGO CA    92121

Business Phone: 858-452-0370
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
4 2010-11-03
4 2010-08-06
4 2010-08-06
4 2010-08-06
4 2010-08-06
4 2010-08-06
4 2010-08-06
3/A 2010-08-02
3/A 2010-08-02
3/A 2010-08-02